| Title: | Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank |
| Journal: | British Journal of Cancer |
| Published: | 16 Apr 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33864017/ |
| DOI: | https://doi.org/10.1038/s41416-021-01392-z |
| URL: | https://www.nature.com/articles/s41416-021-01392-z.pdf |
| Citations: | 40 (25 in last 2 years) as of 8 Aug 2024 |
Publication 4776
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundSome endogenous hormones have been associated with breast cancer risk, but the nature of these relationships is not fully understood.MethodsUK Biobank was used. Hormone concentrations were measured in serum collected in 2006-2010, and in a repeat subsample (N ~ 5000) in 2012-13. Incident cancers were identified through data linkage. Cox regression models were used, and hazard ratios (HRs) corrected for regression dilution bias.ResultsAmong 30,565 pre-menopausal and 133,294 post-menopausal women, 527 and 2,997, respectively, were diagnosed with invasive breast cancer during a median follow-up of 7.1 years. Cancer risk was positively associated with testosterone in post-menopausal women (HR per 0.5 nmol/L increment: 1.18; 95% CI: 1.14, 1.23) but not in pre-menopausal women (pheterogeneity = 0.03), and with IGF-1 (insulin-like growth factor-1) (HR per 5 nmol/L increment: 1.18; 1.02, 1.35 (pre-menopausal) and 1.07; 1.01, 1.12 (post-menopausal); pheterogeneity = 0.2), and inversely associated with SHBG (sex hormone-binding globulin) (HR per 30 nmol/L increment: 0.96; 0.79, 1.15 (pre-menopausal) and 0.89; 0.84, 0.94 (post-menopausal); pheterogeneity = 0.4). Oestradiol, assessed only in pre-menopausal women, was not associated with risk, but there were study limitations for this hormone.ConclusionsThis study confirms associations of testosterone, IGF-1 and SHBG with breast cancer risk, with heterogeneity by menopausal status for testosterone.</p>
3 Authors
- Sandar Tin Tin
- Gillian K. Reeves
- Timothy J. Key
Enabling scientific discoveries that improve human health